Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors

By Jason I. Herschkowitz, K. Simin, V. Weigman, I. Mikaelian, Jerry E. Usary, Zhiyuan Hu, Karen E. Rasmussen, L. Jones, Shahin Assefnia, Subhashini Chandrasekharan and 16 more. Genome Biology, 2007

1,294 citations recorded by the source corpus.

BackgroundAlthough numerous mouse models of breast carcinomas have been developed, we do not know the extent to which any faithfully represent clinically significant human phenotypes. To address this need, we characterized mammary tumor gene expression profiles from 13 different murine models using DNA microarrays and compared the resulting data to those from human breast tumors.ResultsUnsupervised hierarchical clustering analysis showed that six models (TgWAP-Myc, TgMMTV-Neu, TgMMTV-PyMT, TgWAP-Int3, TgWAP-Tag, and TgC3(1)-Tag) yielded tumors with distinctive and homogeneous expression patterns within each strain. However, in each of four other models (TgWAP-T121, TgMMTV-Wnt1, Brca1Co/Co;TgMMTV-Cre;p53+/- and DMBA-induced), tumors with a variety of histologies and expression profiles developed. In many models, similarities to human breast tumors were recognized, including proliferation and human breast tumor subtype signatures. Significantly, tumors of several models displayed characteristics of human basal-like breast tumors, including two models with induced Brca1 deficiencies. Tumors of other murine models shared features and trended towards significance of gene enrichment with human luminal tumors; however, these murine tumors lacked expression of estrogen receptor (ER) and ER-regulated genes. TgMMTV-Neu tumors did not have a significant gene overlap with the human HER2+/ER- subtype and were more similar to human luminal tumors.ConclusionMany of the defining characteristics of human subtypes were conserved among the mouse models. Although no single mouse model recapitulated all the expression features of a given human subtype, these shared expression features provide a common framework for an improved integration of murine mammary tumor models with human breast tumors.

Subfields: Cancer Research, Oncology, Pathology and Forensic Medicine

View Paper: https://www.semanticscholar.org/paper/1eaa5a36705ef228b6d541bb6e49f371cc06afd1

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cancer Research

In Oncology

In Pathology and Forensic Medicine

Citations in the corpus

Collective Invasion in Breast Cancer Requires a Conserved Basal Epithelial Program (2013, background): “By gene expression profiles, MMTV- PyMT tumors cluster with the aggressive luminal B subtype of human breast cancer (Herschkowitz et al., 2007).”
Collective epithelial migration and cell rearrangements drive mammary branching morphogenesis. (2008, background): “The majority of branching morphogenesis occurs during puberty (Figure 1A), but the mammary epithelium also remodels during each cycle of pregnancy, lactation, and involution ( Hennighausen and Robinson, 2005 ).”
Subtypes of Pancreatic Ductal Adenocarcinoma and Their Differing Responses to Therapy (2011, methodology): “To increase power, we merged these two data sets with the distance-weighted discrimination (DWD) metho”
Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers (2009, background): “Basal tumors belong to one of the six major breast tumor subtypes identified on the basis of global gene expression analyses and are among the most aggressiv”
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features (2009, background): “(6) is characterized by the high expression of mesenchymal genes and the low expression of cell–cell contact genes, such as claudins 3, 4, and 7, and E-cadherin.”
Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics. (2009, methodology): “The correlation shown is between the ‘‘tumorigenic’’ signature pattern (Creighton and colleagues, submitted for publication; using ‘‘1’’ and ‘‘-1,’’ for up and down genes, respectively) and each MBC as well an each tumor in the gene expression profile dataset by Herschkowitz and colleagues (9).”
Camera: a competitive gene set test accounting for inter-gene correlation (2012, background): “The first data set profiles 94 breast cancer tumors classified into six molecular subtypes (30,31).”
Modelling breast cancer: one size does not fit all (2007, background): “To determine the extent to which GEM reproduce the molecular features of the human disease, Perou and colleague”
Visualizing stromal cell dynamics in different tumor microenvironments by spinning disk confocal microscopy (2008, positive): “The MMTV-PyMT model shares molecular and histological characteristics with human epidermal growth factor receptor 2 (HER2)-positive breast cancer (Lin et al., 2003; Herschkowitz et al., 2007).”
A Six-Gene Signature Predicts Survival of Patients with Localized Pancreatic Ductal Adenocarcinoma (2010, methodology): “This method has been used previously to successfully combine three breast cancer datasets across three microarray platforms [26], across species [34], and across multiple datasets [35,36].”
Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes (2010, methodology): “This finding is consistent with recent reports that have linked low E-cadherin expression, indicative of passage through an EMT, to clinically encountered breast tumors of either the claudin-low or metaplastic subtype (22, 23).”
Brca1 breast tumors contain distinct CD44+/CD24- and CD133+ cells with cancer stem cell characteristics (2008, background): “1 cells included KRT15, a marker of basal breast cancer type [26], with 17-fold higher expression in RP.”